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Summary
Geminin is an essential cell-cycle protein that is only present
fromSphase to earlymitosis inmetazoan somatic cells [1, 2].
Genetic ablation of geminin in the mouse results in pre-
implantation embryonic lethality because pluripotent cells
fail to form and all cells differentiate to trophoblast [3, 4].
Here we show that geminin is present in G1 phase of mouse
pluripotent cells in contrast to somatic cells, where
anaphase-promoting complex/cyclosome (APC/C)-mediated
proteasomal destruction removes geminin in G1 [1, 2, 5].
Silencing geminin directly or by depleting the APC/C inhib-
itor Emi1 causes loss of stem cell identity and trophoblast
differentiation of mouse embryonal carcinoma and embry-
onic stemcells.Depletionof cyclinsA2orB1doesnot induce
this effect, even though both of these APC/C substrates are
also present during G1 of pluripotent cells. Crucially,
geminin antagonizes the chromatin-remodeling protein
Brg1 to maintain expression of Oct4, Sox2, and Nanog. Our
results define a pluripotency pathway by which suppressed
APC/C activity protects geminin from degradation in G1,
allowing sustained expression of core pluripotency factors.
Collectively, these findings link the cell cycle to the pluripo-
tent state but also raise an unexplained paradox: How is
cell-cycle progression possible in pluripotent cells when
oscillations of key regulatory proteins are lost?
Results and Discussion
The generation of induced pluripotent stem (iPS) cells is an
important but highly inefficient process [6]. A major barrier
that is likely to attenuate reprogramming efficiency is the cell
cycle, which must be modified in mammalian somatic cells
to one that precisely mirrors the cell cycle of embryonic stem
(ES) cells. In contrast to somatic cells, G1 phase of the cell
cycle is severely truncated in ES cells [7]. In mouse ES cells,
cyclin-dependent kinase (cdk) activity is unopposed [8, 9]
and the restriction point is compromised because of a consti-
tutively hyperphosphorylated retinoblastoma protein [10].
Together, these important differences indicate that intrinsic
regulation of the cell cycle might be critical in sustaining the
pluripotent state. Accordingly, c-Myc expression [11, 12],
repression of the INK4/Arf locus [13], and inactivation of the
tumor suppressor p53 [14] are all strategies that perturb the
somatic cell cycle and enhance the efficiency of nuclear
reprogramming in the generation of iPS cells.*Correspondence: mg322@hutchison-mrc.cam.ac.ukWe set out to investigate the requirement of crucial cell-
cycle regulators in maintaining the identity and genome ploidy
of pluripotent cells by transient transfection of small interfering
RNA (siRNA) oligonucleotides using both mouse embryonal
carcinoma (EC) and ES cells. We focused initially on geminin
because we previously observed that mouse embryos that
are null for geminin not only are preimplantation lethal [3, 4]
but also fail to form pluripotent cells [3]. Instead, they form
only trophoblast giant cells. Geminin is a cell-cycle regulator
in multicellular eukaryotes that inhibits prereplication complex
assembly between S phase and the metaphase-anaphase
transition by preventing Cdt1 from recruitingminichromosome
maintenance proteins to chromatin [1–3]. Geminin also
couples cell-cycle control with differentiation during neural
development by interacting with Brg1 [15], Six3 [16], Hox,
and Polycomb complex proteins [17].
We first depleted geminin from asynchronous mouse P19
EC cells (Figure 1A), which are capable of embryonic and
extraembryonic differentiation [18]. This resulted in massive
nuclear enlargement (Figure 1B). Nuclear size was greater at
6 days than at 2 days posttransfection, and the extent of
nuclear enlargement was much greater in EC cells than in
mouse 3T3 fibroblasts (data not shown). Strikingly, depletion
of geminin in P19 EC cells mimics depletion of Oct4 [18]
(also known as Pou5f1; Figures 1A–1E), a core transcription
factor required for self-renewal in ES cells [19]. Depletion of
geminin in P19 EC cells induces markers of trophoblast differ-
entiation (Figure 1B). Thus, immunofluorescent staining with
Troma-1, a trophectoderm-specific monoclonal antibody
raised against cytokeratin endo-A [20], showed upregulation
in geminin-depleted cells (Figures 1C and 1D). Placental cad-
herin (P-cadherin, cadherin-3, Cdh3), the caudal-type homeo-
domain transcription factor Cdx2, and eomesodermin (Eomes)
were also upregulated in geminin-depleted P19 EC cells, but
transcription factors associated with other developmental
lineages were not (Figure 1D; see also Figure S1 available
online). We conclude that geminin depletion causes extraem-
bryonic differentiation into trophoblast, and not differentiation
into other lineages.
Geminin levels in wild-type trophoblast giant cells are much
lower than in their pluripotent counterparts as a result of
proteasomal destruction [3], suggesting that loss of geminin
from trophoblast cells might be mediated by extended activity
of the anaphase-promoting complex/cyclosome (APC/C)
during interphase. In association with specific coactivators,
themultisubunit APC/C polyubiquitinates cell-cycle regulatory
proteins in somatic cells, such as cyclins and Cdk inhibitors,
targeting them for destruction by the 26S proteasome during
mitosis and G1 [21] (Figure 1F). Two coactivator proteins of
the APC/C are Cdc20 and Cdh1. APC/CCdc20 is active from
prophase to the metaphase-anaphase transition. At the meta-
phase-anaphase transition, APC/CCdh1 activity increases and
persists throughout the following G1 until the onset of DNA
replication, when inhibition by early mitotic inhibitor 1 (Emi1)
during S phase prevents further APC/CCdh1 activity until
prophase [22, 23]. To investigate the role of APC/CCdh1 in
pluripotent cells, we depleted its negative regulator, Emi1.
Figure 1G shows that in P19 EC cells, depletion of Emi1 also
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693causes giant cell formation and upregulation of the trophecto-
derm markers Troma-1, P-cadherin, Cdx2, and Eomes (Fig-
ure 1G; Figure S1). To verify that APC/CCdh1 is responsible
for inducing the observed phenotype in pluripotent cells
depleted of Emi1, cells were cotransfected with siRNA
duplexes targeting Cdh1, Emi1, or both together. Codepleting
Emi1 and Cdh1 antagonizes the effect of depleting Emi1 alone,
because nuclear size at 2 days posttransfection was compa-
rable to control cells and considerably smaller than that of
Emi1-depleted cells (Figure S2A). Moreover, codepleting
Cdh1 also inhibited upregulation of trophectoderm markers,
indicating that giant cell formation and trophoblast differentia-
tion in pluripotent cells depleted of Emi1 requires APC/CCdh1.
We next examined whether APC/CCdh1 substrates were
destabilized following depletion of Emi1 in P19 EC cells, partic-
ularly because geminin, cyclin A2, and cyclin B1 are crucial
for cell-cycle regulation and maintenance of a diploid DNA
content in somatic cells. Geminin and cyclin A2-Cdk2
(and Cdk1) prevent illegitimate assembly of prereplication
complexes on chromatinwhenAPC/C activity is low in somatic
cells during S phase and G2 [1, 2, 24, 25], whereas cyclin
B1-Cdk1 initiates mitosis and is required for its progression
[26]. We found that Emi1 depletion resulted in significant
downregulation of geminin, cyclin A2, and cyclin B1 (Figure 2A;
Figures S2B and S2C), as previously observed in somatic cells
[22, 23]. Cyclin E, which is targeted for proteasomal degrada-
tion by the SCFSkp2 ubiquitin ligase [27] and not the APC/C,
was upregulated by immunofluorescence in enlarged nuclei
depleted of Emi1 (Figure S2D). Geminin, cyclin A2, and cyclin
B1 were downregulated in pluripotent cells depleted of Emi1
and dramatically stabilized following treatment with the
proteasome inhibitor MG132 (Figure 2A; Figure S2D). When
we depleted P19 EC cells of cyclin A2, however, cyclin
A2-depleted cells showed minimal upregulation of trophecto-
derm markers, with only a modest increase in DNA content to
4C that could be attributed to a G2 arrest (Figures 2B and 2C),
as observed in somatic cells that have been depleted of cyclin
A2 [28]. Cyclin B1 is also a target of APC/CCdh1, and although
committed trophoblast stem cells are able to endoreduplicate
following p57Kip2-mediated inhibition of Cdk1 [29], we found
that depletion of cyclin B1 alone in pluripotent cells failed to
result in nuclear enlargement or upregulation of trophecto-
derm markers (Figure 2B). These results show that both
trophoblast differentiation and giant cell formation of Emi1-
depleted pluripotent cells can be mimicked by depletion of
geminin only, but not by depletion of cyclins A2 or B1. We
also compared the DNA content of cells depleted of geminin,
cyclin A2, cyclin B1, Emi1, or Oct4 with control siRNA-treated
cells by measuring the relative fluorescence intensity of DAPI
as a function of nuclear volume in individual nuclei. Interest-
ingly, depletion of Emi1 reproducibly induced the highest
accumulation of DNA (Figure 2C).When themeanDNA content
of control P19 EC cells was normalized at 2C, Emi1 depletion
resulted in a 20-fold mean relative increase in DNA content
at 6 days, with a maximum observed of 188C.
Because depletion of geminin or Emi1 induces overreplica-
tion of DNA in human somatic cells [22–24], we asked whether
overreplication might be the trigger for inducing trophecto-
derm markers in mouse pluripotent cells. P19 EC cells were
cotransfected with siRNA duplexes targeting both Emi1 and
the replication protein Cdc6, a component of the prereplica-
tion complex that is essential for the initiation of DNA replica-
tion [30]. After codepleting Emi1 and Cdc6, both nuclear size
and DNA content at 2 days after siRNA transfection weresimilar to control cells (Figure 2D; Figure S2E). However, block-
ing DNA replication in Emi1-depleted cells, either by using
aphidicolin or by codepleting Emi1 and Cdc6, did not inhibit
upregulation of trophectoderm markers (Figure 2D; Figures
S2E and S2F). Hence, although acquisition of a high DNA
content is impaired in EC cells treated with aphidicolin or
codepleted of Emi1 and Cdc6, induction of trophectoderm
markers in Emi1-depleted cells is independent of the effects
of Emi1 on DNA replication.
Following our initial observations in mouse EC cells, we then
examined the phenotypic consequences of depleting geminin,
Emi1, or Oct4 in B6/Blu-1mouse ES cells. Depletion of geminin
or Emi1 in B6/Blu-1 ES cells also mimics depletion of the
pluripotency factor Oct4 in causing upregulation of trophecto-
derm markers at 2 days (Figure 3A; Figure S3A) and at 6 days
(Figure S3B), but not in the extent of nuclear enlargement
observed. Blocking DNA replication by codepletion of Cdc6
and by using aphidicolin (data not shown) again demonstrated
that this effect on ES cells does not depend on DNA replica-
tion, as observed in EC cells. Although Troma-1 and P-cad-
herin were clearly induced, upregulation of Cdx2 or Eomes
and other embryonic differentiation markers was not seen
(Figure S3A). This suggests that extraembryonic differentiation
is not as clear in ES cells as in EC cells or might bypass the
need for these transcription factors. In contrast to our results,
a recent report using A2lox mouse ES cells did not identify any
changes in DNA ploidy or loss of pluripotency following deple-
tion of geminin [31], which might be consistent with the pleio-
tropic effects that have been described following geminin
depletion in somatic cells [32]. However, geminin and Emi1
depletion both result in downregulation of Oct4, Sox2, and
Nanog in both B6/Blu-1 ES cells (Figure 3B) and P19 EC cells
(Figure S3C), indicating that destabilization of geminin, either
directly or by unopposed APC/CCdh1 activity, also causes
loss of pluripotent stem cell identity. Our results support the
interpretation that geminin null mouse embryos fail to form
an inner cell mass because geminin has an additional and
essential role in pluripotency [3, 4], rather than only being
necessary for cell-cycle progression and preventing overrepli-
cation of DNA during embryonic cell divisions [4]. These find-
ings are also consistent with the observation that geminin
restricts multilineage commitment in the early Xenopus
embryo [33].
In mammalian somatic cells, geminin prevents the reinitia-
tion of DNA replication during S phase, G2, and early mitosis
[1, 2, 5, 24], when it is degraded at the metaphase-anaphase
transition by APC/CCdh1. It is absent from G1. Yet if geminin
is required to maintain the expression of pluripotency factors
in ES and EC cells and its depletion induces trophoblast differ-
entiation independently of its effects on DNA replication, why
don’t pluripotent cells differentiate in G1 when geminin is
expected to be absent? We therefore explored the possibility
that regulation of geminin during the cell cycle in pluripotent
cells might differ from its regulation in other cells, as is consis-
tent with a published blot [9]. Chemical synchronization was
not possible because ES or EC cells could not be released
from cell-cycle arrest. However, Figure 3C and Figure S3D
show that geminin is present by immunofluorescence in the
vast majority of asynchronous ES and EC cells, at frequencies
above 90% and equivalent to the pluripotency factor Oct4,
suggesting that it must also be expressed during G1 in plurip-
otent cells. Although part of the difference observed from
somatic cells could conceivably be accounted for by the
higher proportion of pluripotent cells in S phase [7], Figure 3C
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Figure 1. Silencing Geminin or Emi1 Mimics Depletion of the Pluripotency Factor Oct4 in P19 Mouse Embryonal Carcinoma Cells
(A) Geminin, Oct4, and Emi1 were depleted by siRNA in P19 embryonal carcinoma (EC) cells, and whole-cell lysates were harvested for analysis by western
blotting. b-actin was used as a loading control. In mouse cells, a cross-reacting band lies below the Emi1 band marked with an asterisk.
(B) Geminin depletion by siRNA in P19 EC cells results in upregulation of trophectoderm markers Troma-1 and P-cadherin (both in green) and nuclear
enlargement at 2 days and 6 days posttransfection. Total DNA is shown in red. Scale bars represent 20 mm.
(C) Trophectoderm markers Troma-1, P-cadherin, and Cdx2 (in green) are induced in P19 EC cells that lack geminin (purple). The mean proportion of cells
lacking geminin was 67.8% of cells at 24 hr versus 43% at 48 hr as a result of outgrowth of untransfected cells (data not shown).
(D) Bar chart showing lineage analysis of control, geminin-, Oct4-, and Emi1-depleted P19 EC cells. The proportion of cells labeled by immunofluorescence
with markers of extraembryonic (Troma-1, P-cadherin, Cdx2) and embryonic (b-III tubulin, Sox1, Gata6, and Brachyury) differentiation is shown. Eomes is
amarker of bothmesoderm and trophoblast differentiation. At least 1000 cells were scored, and all cells in a given field were scored. Error bars represent 5%
standard error.
(E) Upregulation of trophectoderm markers is observed in P19 EC cells depleted of Oct4 at 2 days and 6 days posttransfection.
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Figure 2. Emi1 Depletion Induces Trophoblast Differentiation in Mouse EC Cells by Downregulation of Geminin, but Not by Downregulation of Cyclins
A2 or B1
(A) Emi1 depletion in P19 EC cells resulted in downregulation of geminin and cyclins A2 and B1 by immunoblotting, with stabilization of each of these APC/C
substrates following treatment with the proteasome inhibitor MG132.
(B) P19 EC cells were transfected with cyclin A2 or cyclin B1 siRNA, and whole-cell lysates were harvested for analysis by western blotting. b-actin was used
as a loading control. Giant cell formation and upregulation of Troma-1 and P-cadherin are not evident following depletion of cyclin A2 or cyclin B1. Total
DNA is shown in red. Scale bars represent 20 mm.
(C) Scatter dot plots show relative DNA content in geminin-, cyclin A2-, cyclin B1-, Emi1-, and Oct4-depleted P19 EC cells relative to control siRNA-treated
cells.
(D) Codepletion of Emi1 and Cdc6 abolishes nuclear enlargement, but not upregulation of trophectodermmarkers Troma-1 and P-cadherin (both green), in
P19 EC cells at 2 days posttransfection. Total DNA is shown in red. Scale bars represent 20 mm. Bar chart shows the proportion of control, Emi1-depleted,
and Emi1- and Cdc6-codepleted P19 EC cells labeled with Troma-1 and P-cadherin by immunofluorescence. At least 1000 cells were scored for each time
point. Error bars represent 5% standard error.
For additional related data, see Figure S2.
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695and Figure S3E show that in contrast to 3T3 fibroblasts, gem-
inin persists outside S phase in most proliferating ES and EC
cells. To resolve when geminin is present during the cell cycle,
we next estimated the duration of individual cell-cycle phases
in exponentially growing 3T3 fibroblasts, ES, and EC cells by
using a combined approach of short and long pulses for
BrdU labeling, scoring labeled mitoses, and flow cytometric(F) Emi1 inhibits APC/CCdh1 activity to drive progression through the mitotic ce
inactivation (or depletion) results in unopposed APC/CCdh1 activity and ubiquit
(G) Emi1 depletion phenocopies depletion of geminin in P19 EC cells with upreg
at 2 days and 6 days. Total DNA is shown in red. Scale bars represent 20 mm.
For additional related data, see Figure S1.analysis. Consistent with published data [7], we found that
ES and EC cells proliferated faster than somatic cells and
that G1 was truncated, with almost 50% of the cell cycle dedi-
cated to S phase (Figure 3D). The observation that geminin is
present in w90% of asynchronously proliferating ES and EC
cells therefore indicates that geminin must also be present
during G1. Mitotic ES cells were also harvested followingll cycle by inhibiting the degradation of geminin and cyclins A2 and B1. Emi1
in-mediated proteasomal destruction of its substrates geminin and cyclins.
ulation of trophectodermmarkers and gross nuclear enlargement observed
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Figure 3. Mouse Embryonic StemCells Lose Expression of the PluripotencyMarkersOct4, Sox2, andNanog and Express TrophoblastMarkers onDepletion
of Geminin and Emi1
(A) Giant cell formation and induction of trophectodermmarkers Troma-1 and P-cadherin (both in green) is evident in B6/Blu-1 mouse embryonic stem (ES)
cells depleted of Emi1, geminin, and Oct4 at 2 days. Total DNA is shown in red. Scale bars represent 20 mm.
(B) Emi1 and geminin depletion in mouse B6/Blu-1 ES cells result in downregulation of the pluripotency transcription factors Oct4, Sox2, and Nanog (in
white). Total DNA is shown in red. Scale bars represent 20 mm.
(C) In B6/Blu-1 ES cells, geminin is coexpressed with Oct4 (geminin and Oct4 both in white). Total DNA is shown in red. Scale bars represent 20 mm. The bar
chart shows that geminin is present in a higher proportion of asynchronous ES and EC cells than in 3T3 fibroblasts, and notably in a far great proportion of
cells that are not actively replicating DNA. Error bars represent 5% standard error.
(D) Table summarizing cell-cycle analyses by immunofluorescence and flow cytometry. In asynchronous populations, the majority of 3T3 fibroblasts are in
G1, in contrast to ES and EC cells in which G1 comprises a small fraction of the cell cycle and the majority of cells are in S phase.
(E) Geminin is present during G1 in ES cells harvested at different time points following mitotic shake-off. Approximately 50% of ES cells enter S phase at
2 hr, suggesting that the duration of G1 phase is likely to be between 2 and 4 hr.
For additional related data, see Figure S3.
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696shake-off and followed through to S phase. Figure 3E confirms
that geminin persists during G1 in ES cells. Because cyclins
are APC/CCdh1 substrates that are also not degraded in ES
cells during G1, S phase, or G2 (Figure 3E) [8, 9], collectively,
these results indicate that APC/CCdh1 activity is suppressed
in interphase ES cells, particularly because its inhibitor Emi1
also persists during G1 (Figure S3F) unlike in somatic cells
when its presence is restricted to S phase, G2, and early
mitosis [34, 35]. Notably, geminin is also detectable by immu-
noblotting at 0, 15, 30, and 45 min following mitotic shake-off.
By immunofluorescence, cytoplasmic geminin was observed
at variable intensity in 98.4% of metaphase ES cells (n = 64),
70.9% of anaphase ES cells (n = 55), and 49.0% of telophaseES cells (n = 51), further indicating that activity of the APC/C
is reduced. During the early embryonic cell cycles of Xenopus,
a significant fraction of geminin (w40%) has also been found
to remain present during mitotic exit [36].
Geminin inhibits neural differentiation in P19 EC cells and
Xenopus embryos by antagonizing the activity of Brg1
(Brahma-related gene 1) [15], the ATPase catalytic subunit of
the SWI/SNF chromatin-remodeling complex that associates
with sequence-specific transcription factors, histone acetyl-
transferases, and histone deacetylases to activate or repress
the expression of target genes [37]. Interestingly, Brg1 also
binds regulatory elements in the Oct4 promoter to repress
Oct4 transcription in the developing trophectoderm of
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(A) Codepletion of geminin and Brg1 abolishes the upregulation of trophectodermmarkers (in green) observed in geminin-depleted ES cells, but not nuclear
enlargement (total DNA, red). Geminin and Brg1 codepletion also blocks the loss of Oct4, Sox2, and Nanog (in white) seen in geminin-depleted ES cells.
Scale bars represent 20 mm.
(B) Bar chart shows that codepletion of geminin and Brg1 rescues the loss of Oct4, Sox2, and Nanog induced by depletion of geminin alone, particularly in
enlarged nuclei.
(C) Codepletion of geminin and Brg1 rescues loss of Sox2 and Nanog in geminin-depleted ES cells. Error bars indicate standard error of the mean using four
housekeeping genes for normalization.
(D) Model of how geminin maintains genomic stability and the pluripotent state in ES cells. Suppressed APC/CCdh1 activity, possibly mediated by Emi1,
stabilizes geminin in ES cells to prevent overreplication of DNA and inhibit repression of the core pluripotency factors Oct4, Sox2, and Nanog by antago-
nizing the chromatin-remodeling protein Brg1.
For additional related data, see Figure S4.
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697preimplantation mouse embryos [38]. We therefore reasoned
that geminin might maintain the undifferentiated state and
prevent trophoblast differentiation in ES cells by antagonizing
Brg1 and blocking Brg1-mediated repression of Oct4. When
we examined Brg1 levels in ES and EC cells depleted of gem-
inin, Brg1 levels did not change (Figure S4A). However,
cotransfection of ES cells with siRNA duplexes targeting
both geminin and Brg1 abolishes the upregulation oftrophectodermmarkers (Figures 4A and 4B). Thus, differentia-
tion in response to geminin depletion depends on Brg1. In
contrast, the effect of geminin depletion on overreplication of
DNA is independent of Brg1. Moreover, Brg1 is required for
geminin depletion to downregulate Oct4, Sox2, and Nanog
(Figures 4A and 4B), an effect also observed at the transcrip-
tional level for Sox2 and Nanog (Figure 4C). Hence, although
Brg1 is not required for overreplication in geminin-depleted
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698cells, downregulation of Oct4, Sox2, and Nanog in geminin-
depleted pluripotent cells requires Brg1.
Our findings indicate that geminin plays a pivotal role in
a pluripotency pathway that links the cell cycle to expression
of core pluripotency factors. We propose a model (Figure 4D)
in which suppression of APC/CCdh1 activity during interphase
in ES cells, possibly mediated by Emi1, ensures that geminin
escapes proteasomal destruction and remains stabilized
during G1. This extends the presence of geminin through
most of the cell cycle, antagonizing Brg1-mediated chromatin
remodeling and preventing repression of Oct4, Sox2, and
Nanog.
Our results explain oneparadoxbut reveal another.We show
that the requirement for geminin to maintain pluripotency is
satisfied by retaining geminin in G1 of pluripotent cells, in
contrast to other cell types. However, these results raise
a second question of how DNA replication is coupled to the
cell cycle in the absence of oscillations of the proteins that nor-
mally achieve this, namelygeminin andcyclinA2. Theextended
presence of geminin through the cell cycle also raises further
interesting questions, such as when and how prereplication
complexes assemble in ES cells. In mammalian somatic cells,
APC/CCdh1-mediated destruction of geminin during mitosis
allows recruitment of Cdt1 onto chromatin and formation of
new prereplication complexes [1, 2]. We therefore speculate
that geminin might only be absent in mouse ES cells for
a very short window during late telophase, or in very early G1,
to allow prereplication complexes to assemble. Alternatively,
posttranslational modifications similar to those observed for
Xenopus geminin, which is not destroyed in mitotic egg
extracts but inactivated by ubiquitination [39], might prevent
the binding of geminin toCdt1 duringG1 inmammalianEScells
without affecting its ability to antagonize Brg1. A further ques-
tion emerges: How is suppression of APC/C activity compat-
ible with progression through the cell cycle in ES cells when
oscillations in each of its substrates are lost? Such new ques-
tions into the control of the cell cycle in ES cells demand urgent
attention, particularly when considering novel approaches for
enhancing the efficiency of nuclear reprogramming by defined
transcription factors in the generation of iPS cells.
Experimental Procedures
Cell Culture
P19 EC cells (American Type Culture Collection) were grown in a-modified
Eagle’s medium (Sigma-Aldrich) supplemented with 7.5% donor bovine
serum, 2.5% fetal bovine serum (FBS), 2 mM L-glutamine, 100 units/ml
penicillin, and 0.1 mg/ml streptomycin (GIBCO). NIH 3T3 fibroblasts
(European Collection of Cell Cultures) were grown in Dulbecco’s modified
Eagle’s medium (DMEM; GIBCO) supplemented with 15% fetal calf serum,
100 units/ml penicillin, and 0.1 mg/ml streptomycin. B6/Blu-1 ES cells were
maintained in KnockOut DMEM (GIBCO), supplemented with 15% FBS,
10 pM b-mercaptoethanol (Sigma-Aldrich), 1000 U/ml LIF (Millipore),
2 mM L-glutamine (AMRESCO), 0.012 g/ml penicillin, and 0.02 g/ml strepto-
mycin on 0.1% gelatin-coated flasks.
RNA Interference
siRNA duplexes were synthesized by QIAGEN and designed to target the
relevant sequences (see Supplemental Experimental Procedures). Control
siRNAs were designed by substitution of two base pairs for each sequence.
P19 EC cells, NIH 3T3 fibroblasts, and B6/Blu-1 ES were transfected using
Oligofectamine (Invitrogen), LipofectamineRNAiMax (Invitrogen), or ‘‘Nucle-
ofector’’ technology (Lonza) according to manufacturers’ instructions.
Immunoblotting and Immunofluorescence
For immunoblotting, cells were lysed directly in 23 Laemmli sample buffer
(350 nM Tris-HCl [pH 6.5], 10% glycerol, 3% sodium dodecyl sulfate[SDS], 3% dithiothreitol, 2.7% bromophenol blue), boiled, and run on
polyacrylamide Tris-glycine gels (Invitrogen). Proteins were transferred to
a polyvinylidene difluoride membrane. Blocking of membranes and incuba-
tion steps with the appropriate primary antibodies (see Supplemental
Experimental Procedures) and HRP-conjugated secondary antibodies
(Dako) were performed in 5% milk in 0.1% Tween 20/phosphate-buffered
saline. Antibodies were detected using ECL (GE Healthcare).
For BrdU or EdU immunofluorescence, cells were incubated with 20 mM
BrdU or 10 mM EdU prior to fixation in 4% paraformaldehyde. For immuno-
fluorescent staining of cyclin E, cells were permeabilized with 0.1% Triton X-
100 on ice prior to fixation. Cells were permeabilized with 0.1% Triton X-100
and 0.02% SDS, blocked with 1% BSA (Sigma-Aldrich), and incubated with
primary antibody. Coverslips were incubated with Alexa Fluor-conjugated
secondary antibodies (Molecular Probes) and DAPI (Sigma-Aldrich),
mounted with fluorescence mounting medium (Dako), and sealed with nail
varnish. Confocal imageswere collected on a Zeiss LSM510METAconfocal
microscope and rendered using its image browser software (Carl Zeiss
MicroImaging). Serial confocal sections (Z stacks) were collected at
0.25 mm intervals and compiled into a single image for semiquantitative
assessment of DNA content using Volocity LE 3.0.2 software (Improvision).
Cell-Cycle Analysis
The average length of a single cell cycle was calculated as the time required
for exponentially proliferating cells to double in number. The S phase frac-
tion was determined by the proportion of asynchronously proliferating cells
that had incorporated BrdU after a 20 min pulse. Mitotic cells were quanti-
fied by DAPI staining. Fractions were then multiplied by the total length of
the cell cycle to obtain estimates of the duration of each phase. The average
length of G2 was estimated from the length of BrdU pulse required to label
half themitotic cells in asynchronously proliferating cell populations [40]. G1
was then calculated by subtracting the lengths of S phase, G2, and mitosis
from the length of a single cell cycle. For flow cytometry, cells were trypsi-
nized and fixed in ice-cold 70% methanol before staining with propidium
iodide (Sigma-Aldrich) and analyzed for DNA content using BD LSR II and
FACSDiva software (Becton Dickinson).
Supplemental Information
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.
1016/j.cub.2011.03.026.
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